Medicines Company

$35.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.76 (-2.12%) As of 1:40 PM EDT today
-$0.76 (-2.12%) Today

Why Robinhood?

You can buy or sell MDCO and other stocks, options, ETFs, and crypto commission-free!

About MDCO

Medicines Company (The) Common Stock, also called Medicines Company, is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. Read More The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.

Employees
62
Headquarters
Parsippany, New Jersey
Founded
1996
Market Cap
2.84B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.23M
High Today
$36.92
Low Today
$34.85
Open Price
$35.62
Volume
610.95K
52 Week High
$41.33
52 Week Low
$16.69

Collections

MDCO News

BenzingaAug 20

Biotech Stock On The Radar: Medicines Company, A Cardiovascular Pure Play With A Potential Blockbuster

64
BenzingaAug 20

The Medicines Company, Alnylam Pharmaceuticals, Inc. - Biotech Stock On The Radar: Medicines Company, A Cardiovascular Pure Play With A Potential Blockbuster

29
ReutersJul 30

Edited Transcript of MDCO earnings conference call or presentation 24-Jul-19 12:30pm GMT

15

MDCO Earnings

-$1.28
-$1.04
-$0.79
-$0.55
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 6, Pre-Market

More MDCO News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.